F9错义突变损害凝血因子IX活化并与多效性血浆表型相关
研究检测了FIX活化位点(R191-R226)错义突变在血浆和重组表达中的活性与抗原水平,并分析了30例血友病B患者的输注FIX药代动力学。结果显示不同R191/R226替换导致FIX抗原量及病情严重程度呈梯度变化,且内源性FIX抗原水平与输注FIX的分布和消除相正相关,R191/R226突变患者平均驻留时间延长。
要点
- R191C>L>P>H替换导致FIX抗原量和病情严重程度呈梯度递减。
- R226Q/W/P替换比R191等效替换产生更高FIX抗原水平。
- R191/R226突变患者输注FIX的平均驻留时间延长至79.4小时。
核心结论
- FIX活化位点R191/R226错义突变导致功能异常的FIX变体,对血友病B患者表型和替代治疗产生多效性影响。
研究设计与样本
- 检测FIX活性和抗原,并在血浆及重组表达FIX变体后分析,同时对30例患者进行输注FIX药代动力学分析,多数来自GePKHIS研究。
主要发现
- 多个R191变体的FIX抗原量可变,生物合成与活性良好相关,导致R191C>L>P>H替换呈中至轻度梯度严重性。
- 重组表达预测HB突变数据库中良性R191Q/W/K和R226K替换缺失,等效R191/R226改变中R226Q/W/P产生更高FIX抗原水平。
- 患者药代动力学分析提示输注FIX的Alpha分布相和Beta消除相与内源性FIX抗原水平正相关。
临床怎么用
- 对携带FIX活化位点R191/R226突变的血友病B患者,输注FIX时需考虑内源性FIX抗原水平对药代动力学的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Circulating dysfunctional factor IX (FIX) might modulate distribution of infused FIX in hemophilia B (HB) patients. Recurrent substitutions at FIX activation sites (R191-R226, >300 patients) are associated with variable FIX activity and antigen (FIXag) levels. OBJECTIVES: To investigate the (1) expression of a complete panel of missense mutations at FIX activation sites and (2) contribution of F9 genotypes on the FIX pharmacokinetics (PK). METHODS: We checked FIX activity and antigen and activity assays in plasma and after recombinant expression of FIX variants and performed an analysis of infused FIX PK parameters in patients (n = 30), mostly enrolled in the F9 Genotype and PK HB Italian Study (GePKHIS; EudraCT ID2017-003902-42). RESULTS: The variable FIXag amounts and good relation between biosynthesis and activity of multiple R191 variants results in graded moderate-to-mild severity of the R191C>L>P>H substitutions. Recombinant expression may predict the absence in the HB mutation database of the benign R191Q/W/K and R226K substitutions. Equivalent changes at R191/R226 produced higher FIXag levels for R226Q/W/P substitutions, as also observed in p.R226W female carrier plasma. Pharmacokinetics analysis in patients suggested that infused FIX Alpha distribution and Beta elimination phases positively correlated with endogenous FIXag levels. Mean residence time was particularly prolonged (79.4 h, 95% confidence interval 44.3-114.5) in patients (n = 7) with the R191/R226 substitutions, which in regression analysis were independent predictors (β coefficient 0.699, P = .004) of Beta half-life, potentially prolonged by the increasing over time ratio between endogenous and infused FIX. CONCLUSIONS: FIX activity and antigen levels and specific features of the dysfunctional R191/R226 variants may exert pleiotropic effects both on HB patients' phenotypes and substitutive treatment.
引用
- Branchini A, Morfini M, Lunghi B, et al. F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes. J Thromb Haemost. 2021. PMID: 34626083. doi:10.1111/jth.15552
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。